DxS enters pact with Pfizer
By New Statesman - 08 February 10:52

Pfizer and DxS, a wholly owned subsidiary of Qiagen have entered into an agreement to develop a comp

FDA clears Toshiba Viamo ultrasound system
By New Statesman - 05 February 10:32

Toshiba America Medical Systems (Toshiba) has received FDA clearance for its new 'Viamo' laptop ultr

Mintaka Foundation for medical research receives £2.7m for HIV research
By New Statesman - 05 February 10:30

The Mintaka Foundation for Medical Research in Geneva has received fund of £2.7m from Wellcome Trust

Avexa ATC trial data shows benefits for HIV patients
By New Statesman - 05 February 10:28

Avexa's Apricitabine (ATC) data has shown to be beneficial at 24 week therapy against the traditiona

Ipsen, Debiopharm launch cancer drug in France
By New Statesman - 05 February 10:26

Ipsen and its partner, Debiopharm, have launched Decapeptyl LP 22.5mg, a sustained release drug for

Seattle Genetics, Millennium initiate Phase I Hodgkin Lymphoma drug trial
By New Statesman - 05 February 10:24

Seattle Genetics and Millennium Pharmaceuticals, a wholly-owned subsidiary of Takeda Pharmaceutical,

Pall introduces new blood filter
By New Statesman - 04 February 11:09

Pall Corporation (Pall) has launched Leukotrap Affinity Plus Prion and Leukocyte Reduction Filter Sy

Roche's 2009 operating profit up 14 per cent
By New Statesman - 04 February 11:07

Roche group has posted a strong performance for the financial year 2009 compared to the previous yea

NeuroSearch reports positive Phase III Huntexil study results
By New Statesman - 04 February 11:04

NeuroSearch has reported positive top-line results from the MermaiHD study, the European phase III s

Recordati Silodosin gets European approval in BPH treatment
By New Statesman - 04 February 11:00

Recordati has been granted marketing authorization by the European Commission for the medicinal prod

Daiichi Sankyo initiates Phase III Edoxaban trial
By New Statesman - 04 February 10:58

Daiichi Sankyo has initiated a new large-scale phase III trial for Edoxaban, its investigational ora

Thermo Fisher to acquire Finnzymes
By New Statesman - 03 February 10:16

Thermo Fisher Scientific (Thermo Fisher) has signed a definitive agreement to acquire Finland-based

Siemens Healthcare, Vertec form distribution partnership
By New Statesman - 03 February 10:15

Siemens Healthcare (Siemens) and Vertec Scientific (Vertec) have entered into a distribution agreeme

Abbott to collaborate with Pierre Fabre on cancer research
By New Statesman - 03 February 10:13

Abbott has signed an exclusive worldwide licensing agreement with Pierre Fabre to develop and commer

FDA approves Allergan's new Juvederm formulation
By New Statesman - 03 February 10:12

Allergan has announced that FDA has approved Juvederm XC, a new formulation of the currently FDA-app

FDA approves Xiaflex of BioSpecifics
By New Statesman - 03 February 10:09

The FDA has approved BioSpecifics Technologies' (BioSpecifics) Xiaflex, a new orphan-designated, bio

Elan Pharmaceuticals to implement Infosys' co-creation model
By New Statesman - 02 February 11:54

Infosys Technologies will design and implement the Research Informatics System (RISe) at Elan Pharma

Keller-Crescent takes over Lehigh Press
By New Statesman - 02 February 11:52

Keller-Crescent, a supplier of printed pharmaceutical folding cartons, inserts and outserts, pharmac

Cordis, Boston Scientific settle coronary stent patent disputes
By New Statesman - 02 February 11:50

Cordis, a Johnson & Johnson company, has reached an agreement with Boston Scientific resolving two D

KIKA renews ISO certification for US, French operations
By New Statesman - 02 February 11:48

KIKA Clinical Solutions (KIKA), a provider of advanced EDC solutions for Clinical Asset Management t

Victoria Court implements Cytopia, YM BioSciences merger
By New Statesman - 02 February 11:46

The Supreme Court of Victoria has approved the Scheme of Arrangement between Cytopia and its shareho

Dishman pharma begins API facility in Ahmedabad, India
By New Statesman - 01 February 11:13

Dishman Pharmaceuticals and Chemicals (Dishman Pharma) has commissioned its high containment API fac

Invatec reports clinical results of drug eluting balloon technology
By New Statesman - 01 February 11:07

Invatec, an innovator of interventional products, has reported the first clinical results of the Dru

Flexion enters into agreements with four pharma majors
By New Statesman - 01 February 10:59

Flexion Therapeutics (Flexion) has signed agreements with four major pharmaceutical partners, acquir

Cadila awaits Indian approval for VLP technology
By New Statesman - 01 February 10:55

Cadila Pharmaceuticals' (Cadila) plan to use virus-like particle (VLP) technology for the developmen

Sanofi-aventis to establish new consumer healthcare JV in China
By New Statesman - 01 February 10:46

Sanofi-aventis has signed agreements with Minsheng Pharmaceutical to form a new consumer healthcare

AstraZeneca to shed 8000 jobs
By New Statesman - 29 January 13:48

AstraZeneca plans to save costs by cutting 8,000 jobs worldwide over the next five years and outsour

FDA approves Fujifilm's FDR AcSelerate system
By New Statesman - 29 January 10:29

Fujifilm Medical Systems (Fujifilm) has received FDA 510(k) approval for the Fuji Digital Radiograph

Gastroenterology group seals agreement with NeuIsys
By New Statesman - 29 January 10:14

NeuIsys Imaging System Solutions (NeuIsys), a provider of CT and MR imaging systems to physician pra

LifeScan launches One Touch Verio in Netherlands
By New Statesman - 29 January 10:11

Universal Biosensors (UBI), a specialist medical diagnostics company, said that its partner LifeScan

Pages